Haemonetics (HAE) PT Raised to $142 at Needham & Company, Following Earnings
Get Alerts HAE Hot Sheet
Price: $87.22 --0%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 6
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 6
Join SI Premium – FREE
Needham & Company analyst Mike Matson raised the price target on Haemonetics (NYSE: HAE) to $142.00 (from $138.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shattuck Labs (STTK) PT Lowered to $14 at H.C. Wainwright
- eToro Group (ETOR) PT Lowered to $53 at Needham
- Hims and Hers (HIMS) PT Raised to $42 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Needham & Company, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share